Single-domain antibodies for biomedical applications

被引:55
|
作者
Krah, Simon [1 ]
Schroeter, Christian [1 ]
Zielonka, Stefan [2 ]
Empting, Martin [3 ]
Valldorf, Bernhard [2 ]
Kolmar, Harald [2 ]
机构
[1] Merck KGaA, Merck Serono, Prot Engn & Antibody Technol, Darmstadt, Germany
[2] Tech Univ Darmstadt, Inst Organ Chem & Biochem, Alarich Weiss Str 4, D-64287 Darmstadt, Germany
[3] Univ Saarland, Helmholtz Inst Pharmaceut Res Saarland HIPS, Dept Drug Design & Optimizat, D-66123 Saarbrucken, Germany
关键词
VHH; heavy chain antibody; Antibody engineering; antibody fragment; single chain binding domain; IgNAR; SHARK IGNAR ANTIBODY; ANTIGEN RECEPTOR IGNAR; VARIABLE DOMAINS; BIOPHYSICAL PROPERTIES; AFFINITY MATURATION; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; SELECTION; FRAGMENTS; NANOBODY;
D O I
10.3109/08923973.2015.1102934
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Single-domain antibodies are the smallest antigen-binding units of antibodies, consisting either only of one variable domain or one engineered constant domain that solely facilitates target binding. This class of antibody derivatives comprises naturally occurring variable domains derived from camelids and sharks as well as engineered human variable or constant antibody domains of the heavy or light chain. Because of their high affinity and specificity as well as stability, small size and benefit of multiple re-formatting opportunities, those molecules emerged as promising candidates for biomedical applications and some of these entities have already proven to be successful in clinical development.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [21] Single-domain antibodies as building blocks for novel therapeutics
    Saerens, Dirk
    Ghassabeh, Gholamreza Hassanzadeh
    Muyldermans, Serge
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (05) : 600 - 608
  • [22] Photobodies: Light-activatable single-domain antibodies
    Jedlitzke B.
    Yilmaz Z.
    Mootz H.D.
    BIOspektrum, 2020, 26 (3) : 273 - 275
  • [23] Single-Domain Antibodies or Nanobodies: A Class of Next-Generation Antibodies
    Khodabakhsh, Farnaz
    Behdani, Mahdi
    Rami, Abbas
    Kazemi-Lomedasht, Fatemeh
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2018, 37 (06) : 316 - 322
  • [24] Engineered single-domain antibodies tackle COVID variants
    James E. Voss
    Nature, 2021, 595 : 176 - 178
  • [25] CAMELID SINGLE-DOMAIN ANTIBODIES: MORE NEW FEATURES.
    Decanniere, K.
    Desmyter, A.
    Lauwereys, M.
    Muyldermans, S.
    Wyns, L.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 1999, 55 : 349 - 350
  • [26] Multivalent Anchoring and Oriented Display of Single-Domain Antibodies on Cellulose
    Hussack, Greg
    Luo, Yan
    Veldhuis, Linda
    Hall, J. Christopher
    Tanha, Jamshid
    MacKenzie, Roger
    SENSORS, 2009, 9 (07): : 5351 - 5367
  • [27] A new generation of anti-hapten antibodies:: Single-domain llama antibodies
    Alvarez, N.
    Behar, G.
    Baty, D.
    Barbet, J.
    Aubry, J.
    Birkle, S.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2006, 21 (04) : 399 - 399
  • [28] Development of single-domain recombinant antibodies to reverse transcriptase domain of human hTERT
    Huang, MY
    Zhang, B
    Wang, JM
    Mei, F
    Hou, L
    HYBRIDOMA AND HYBRIDOMICS, 2004, 23 (04): : 244 - 249
  • [29] Analysis and Modeling of the Variable Region of Camelid Single-Domain Antibodies
    Sircar, Aroop
    Sanni, Kayode A.
    Shi, Jiye
    Gray, Jeffrey J.
    JOURNAL OF IMMUNOLOGY, 2011, 186 (11): : 6357 - 6367
  • [30] Development of a platform process for the production and purification of single-domain antibodies
    Crowell, Laura E.
    Goodwine, Chaz
    Holt, Carla S.
    Rocha, Lucia
    Vega, Celina
    Rodriguez, Sergio A.
    Dalvie, Neil C.
    Tracey, Mary K.
    Puntel, Mariana
    Wigdorovitz, Andres
    Parreno, Viviana
    Love, Kerry R.
    Cramer, Steven M.
    Love, J. Christopher
    BIOTECHNOLOGY AND BIOENGINEERING, 2021, 118 (09) : 3348 - 3358